NZ266146A - Glycoproteins expressed from mammalian cell lines - Google Patents

Glycoproteins expressed from mammalian cell lines

Info

Publication number
NZ266146A
NZ266146A NZ266146A NZ26614694A NZ266146A NZ 266146 A NZ266146 A NZ 266146A NZ 266146 A NZ266146 A NZ 266146A NZ 26614694 A NZ26614694 A NZ 26614694A NZ 266146 A NZ266146 A NZ 266146A
Authority
NZ
New Zealand
Prior art keywords
glycoprotein
cell line
medium
cells
protein
Prior art date
Application number
NZ266146A
Other languages
English (en)
Inventor
Hans Wolf
Klaus Scharfenberg
Roland Wagner
Original Assignee
Hans Wolf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hans Wolf filed Critical Hans Wolf
Publication of NZ266146A publication Critical patent/NZ266146A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16211—Lymphocryptovirus, e.g. human herpesvirus 4, Epstein-Barr Virus
    • C12N2710/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NZ266146A 1993-04-26 1994-04-26 Glycoproteins expressed from mammalian cell lines NZ266146A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4313620A DE4313620A1 (de) 1993-04-26 1993-04-26 Hamsterzellinien und Verfahren zur Glykoproteingewinnung
PCT/EP1994/001318 WO1994025599A1 (de) 1993-04-26 1994-04-26 Säugerzellinien und verfahren zur glykoproteingewinnung

Publications (1)

Publication Number Publication Date
NZ266146A true NZ266146A (en) 1997-11-24

Family

ID=6486397

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ266146A NZ266146A (en) 1993-04-26 1994-04-26 Glycoproteins expressed from mammalian cell lines

Country Status (9)

Country Link
EP (1) EP0695357A1 (ja)
JP (1) JPH08509369A (ja)
KR (1) KR100255228B1 (ja)
CN (1) CN1124502A (ja)
AU (1) AU6722094A (ja)
CA (1) CA2161517A1 (ja)
DE (1) DE4313620A1 (ja)
NZ (1) NZ266146A (ja)
WO (1) WO1994025599A1 (ja)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6475725B1 (en) 1997-06-20 2002-11-05 Baxter Aktiengesellschaft Recombinant cell clones having increased stability and methods of making and using the same
AT409379B (de) 1999-06-02 2002-07-25 Baxter Ag Medium zur protein- und serumfreien kultivierung von zellen
JP2003506077A (ja) * 1999-08-05 2003-02-18 バクスター アクチェンゲゼルシャフト 組換え安定細胞クローン、その産生およびその使用
EP2287288B1 (en) 2002-07-09 2012-11-07 Baxter International Inc. Animal protein free media for cultivation of cells
TWI384069B (zh) * 2004-08-27 2013-02-01 Pfizer Ireland Pharmaceuticals 多胜肽之製法
US20060094104A1 (en) 2004-10-29 2006-05-04 Leopold Grillberger Animal protein-free media for cultivation of cells
EP1974014B1 (en) 2006-01-04 2017-04-19 Baxalta Incorporated Oligopeptide-free cell culture media
JP5995397B2 (ja) * 2009-03-09 2016-09-21 東洋製罐グループホールディングス株式会社 細胞培養方法、及び細胞培養装置
JP2011004754A (ja) * 2010-08-05 2011-01-13 Baxter Ag 組換え安定細胞クローン、その産生およびその使用
WO2014062535A1 (en) 2012-10-15 2014-04-24 Bristol-Myers Squibb Company Mammalian cell culture processes for protein production
JP6097725B2 (ja) * 2014-07-09 2017-03-15 バクスアルタ・イノベイションズ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツングＢａｘａｌｔａ Ｉｎｎｏｖａｔｉｏｎｓ ＧｍｂＨ 組換え安定細胞クローン、その産生およびその使用
JP6245299B2 (ja) * 2016-04-27 2017-12-13 バクスアルタ ゲーエムベーハー 組換え安定細胞クローン、その産生およびその使用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO162160C (no) * 1987-01-09 1989-11-15 Medi Cult As Serumfritt vekstmedium, samt anvendelse derav.
EP0312164A1 (en) * 1987-10-16 1989-04-19 Merck & Co. Inc. Purification of recombinant epstein-barr virus antigens from vero cells, yeast cells or L cells
GB9022545D0 (en) * 1990-10-17 1990-11-28 Wellcome Found Culture medium
JPH04228066A (ja) * 1990-10-23 1992-08-18 Rikagaku Kenkyusho 外来遺伝子発現用培養細胞

Also Published As

Publication number Publication date
AU6722094A (en) 1994-11-21
CA2161517A1 (en) 1994-11-10
KR100255228B1 (ko) 2000-05-01
JPH08509369A (ja) 1996-10-08
DE4313620A1 (de) 1994-10-27
WO1994025599A1 (de) 1994-11-10
CN1124502A (zh) 1996-06-12
EP0695357A1 (de) 1996-02-07

Similar Documents

Publication Publication Date Title
JP6467459B2 (ja) 細胞の無タンパク質かつ無血清の培養のための培地
RU2222547C2 (ru) Получение рекомбинантного фактора viii в среде, не содержащей белка
US6475725B1 (en) Recombinant cell clones having increased stability and methods of making and using the same
JP3313117B2 (ja) ウイルス粒子の効率の高い生産および単離
NZ266146A (en) Glycoproteins expressed from mammalian cell lines
EP1200561B1 (de) Rekombinanter stabiler zellklon, seine herstellung und verwendung
US7666654B2 (en) Method for preparing viral material
AU1369801A (en) Mammal cell lines and method of obtaining glycoproteins
AU2011211462B2 (en) Improved process for the culturing of cells
AT409493B (de) Stabiler rekombinanter zellklon
MXPA98003051A (en) Preparation of recombinant factor viii in a protei free medium
Hesse et al. Application of Protein-Free Cell Culture Media for the Manufacturing of Biopharmaceuticals